NYSE: $LLY New Hope for Heart Health in Type 2 Diabetes In a significant development for patients living with type 2 diabetes, the FDA has approved an updated indication for Mounjaro (tirzepatide). While widely recognized for its efficacy in glycemic control, the medication is now officially indicated to help reduce the risk of major adverse…